⁶⁸Ga-labelled somatostatin analogues

Clinical Evaluation	Somatostatin receptor expression
Type of Imaging	PET
Grade of Recommendation	B (generally recommended)
Level of Evidence	well-established clinical and Nuclear Medicine recommendations
Effective Dose	17.0-23.0 µSv/MBq
Bibliographic Reference	Bozkurt, M.F., Virgolini, I., Balogova, S., Beheshti, M., Rubello, D., Decristoforo, C., Ambrosini, V., Kjaer, A., Delgado-Bolton, R., Kunikowska, J.,... read more Bozkurt, M.F., Virgolini, I., Balogova, S., Beheshti, M., Rubello, D., Decristoforo, C., Ambrosini, V., Kjaer, A., Delgado-Bolton, R., Kunikowska, J., Oyen, W.J.G., Chiti, A., Giammarile, F., Sundin, A., Fanti, S. Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA. Eur J Nucl Med Mol Imaging,2017; https://doi.org/10.1007/s00259-017-3728-y read less
Guide to Nuclear Medicine	Read the corresponding chapter

Clinical Evaluation
Somatostatin receptor expression
Type of Imaging
PET
Grade of Recommendation
B (generally recommended)
Level of Evidence
well-established clinical and Nuclear Medicine recommendations
Effective Dose
17.0-23.0 µSv/MBq
Bibliographic Reference
Bozkurt, M.F., Virgolini, I., Balogova, S., Beheshti, M., Rubello, D., Decristoforo, C., Ambrosini, V., Kjaer, A., Delgado-Bolton, R., Kunikowska, J.,... read more Bozkurt, M.F., Virgolini, I., Balogova, S., Beheshti, M., Rubello, D., Decristoforo, C., Ambrosini, V., Kjaer, A., Delgado-Bolton, R., Kunikowska, J., Oyen, W.J.G., Chiti, A., Giammarile, F., Sundin, A., Fanti, S. Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA. Eur J Nucl Med Mol Imaging,2017; https://doi.org/10.1007/s00259-017-3728-y read less
Guide to Nuclear Medicine
Read the corresponding chapter

68Ga-labelled somatostatin analogues